Study of the antisecretory and antiulcer mechanisms of a new indenopirydazinone derivative in rats

E. Barocelli, M. Chiavarini, V. Ballabeni, D. Barlocco, P. Vianello, V. Dal Piaz, M. Impicciatore

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The present study investigates the antisecretory and antiulcer mechanisms of a new indenopyridazinone derivative previously reported to inhibit gastric acid secretion in pylorus-ligated rats and to prevent gastric ulcerations induced by indomethacin or ethanol in the same animal species. The new compound was tested on the acid hypersecretion induced by histamine, pentagastrin and bethanechol in in vivo and in vitro experimental models. Furthermore, its influence on the mucosal layer adhering the gastric wall in indomethacin-treated rats was considered. Ranitidine was selected as a reference drug. The results obtained demonstrated that the new molecule, at variance with ranitidine, exerts antiulcer activity mainly enhancing the gastric mucosal integrity and simultaneously inhibiting the gastric acid hypersecretion evoked exclusively by cholinergic pulses. Therefore, an involvement of a neuronal rather than an effectorial mechanism has been suggested. Due to these mechanisms of action it clearly differentiates from ranitidine and its possible application in the peptic disease resistant to H2-blockers could be speculated.

Original languageEnglish
Pages (from-to)487-492
Number of pages6
JournalPharmacological Research
Volume35
Issue number5
DOIs
Publication statusPublished - May 1997

Fingerprint

Ranitidine
Stomach
Gastric Acid
Indomethacin
Bethanechol
Pentagastrin
Pylorus
Cholinergic Agents
Histamine
Digestion
Ethanol
Theoretical Models
Acids
Pharmaceutical Preparations

Keywords

  • Antiulcer-antisecretory activity
  • Gastric mucosal barrier
  • In vivo-in vitro functional assays
  • Indenopirydazinone derivative
  • Ranitidine

ASJC Scopus subject areas

  • Pharmacology

Cite this

Barocelli, E., Chiavarini, M., Ballabeni, V., Barlocco, D., Vianello, P., Dal Piaz, V., & Impicciatore, M. (1997). Study of the antisecretory and antiulcer mechanisms of a new indenopirydazinone derivative in rats. Pharmacological Research, 35(5), 487-492. https://doi.org/10.1006/phrs.1997.0168

Study of the antisecretory and antiulcer mechanisms of a new indenopirydazinone derivative in rats. / Barocelli, E.; Chiavarini, M.; Ballabeni, V.; Barlocco, D.; Vianello, P.; Dal Piaz, V.; Impicciatore, M.

In: Pharmacological Research, Vol. 35, No. 5, 05.1997, p. 487-492.

Research output: Contribution to journalArticle

Barocelli, E, Chiavarini, M, Ballabeni, V, Barlocco, D, Vianello, P, Dal Piaz, V & Impicciatore, M 1997, 'Study of the antisecretory and antiulcer mechanisms of a new indenopirydazinone derivative in rats', Pharmacological Research, vol. 35, no. 5, pp. 487-492. https://doi.org/10.1006/phrs.1997.0168
Barocelli E, Chiavarini M, Ballabeni V, Barlocco D, Vianello P, Dal Piaz V et al. Study of the antisecretory and antiulcer mechanisms of a new indenopirydazinone derivative in rats. Pharmacological Research. 1997 May;35(5):487-492. https://doi.org/10.1006/phrs.1997.0168
Barocelli, E. ; Chiavarini, M. ; Ballabeni, V. ; Barlocco, D. ; Vianello, P. ; Dal Piaz, V. ; Impicciatore, M. / Study of the antisecretory and antiulcer mechanisms of a new indenopirydazinone derivative in rats. In: Pharmacological Research. 1997 ; Vol. 35, No. 5. pp. 487-492.
@article{3b2d327eda024a36880f31dab058f58a,
title = "Study of the antisecretory and antiulcer mechanisms of a new indenopirydazinone derivative in rats",
abstract = "The present study investigates the antisecretory and antiulcer mechanisms of a new indenopyridazinone derivative previously reported to inhibit gastric acid secretion in pylorus-ligated rats and to prevent gastric ulcerations induced by indomethacin or ethanol in the same animal species. The new compound was tested on the acid hypersecretion induced by histamine, pentagastrin and bethanechol in in vivo and in vitro experimental models. Furthermore, its influence on the mucosal layer adhering the gastric wall in indomethacin-treated rats was considered. Ranitidine was selected as a reference drug. The results obtained demonstrated that the new molecule, at variance with ranitidine, exerts antiulcer activity mainly enhancing the gastric mucosal integrity and simultaneously inhibiting the gastric acid hypersecretion evoked exclusively by cholinergic pulses. Therefore, an involvement of a neuronal rather than an effectorial mechanism has been suggested. Due to these mechanisms of action it clearly differentiates from ranitidine and its possible application in the peptic disease resistant to H2-blockers could be speculated.",
keywords = "Antiulcer-antisecretory activity, Gastric mucosal barrier, In vivo-in vitro functional assays, Indenopirydazinone derivative, Ranitidine",
author = "E. Barocelli and M. Chiavarini and V. Ballabeni and D. Barlocco and P. Vianello and {Dal Piaz}, V. and M. Impicciatore",
year = "1997",
month = "5",
doi = "10.1006/phrs.1997.0168",
language = "English",
volume = "35",
pages = "487--492",
journal = "Pharmacological Research",
issn = "1043-6618",
publisher = "Academic Press",
number = "5",

}

TY - JOUR

T1 - Study of the antisecretory and antiulcer mechanisms of a new indenopirydazinone derivative in rats

AU - Barocelli, E.

AU - Chiavarini, M.

AU - Ballabeni, V.

AU - Barlocco, D.

AU - Vianello, P.

AU - Dal Piaz, V.

AU - Impicciatore, M.

PY - 1997/5

Y1 - 1997/5

N2 - The present study investigates the antisecretory and antiulcer mechanisms of a new indenopyridazinone derivative previously reported to inhibit gastric acid secretion in pylorus-ligated rats and to prevent gastric ulcerations induced by indomethacin or ethanol in the same animal species. The new compound was tested on the acid hypersecretion induced by histamine, pentagastrin and bethanechol in in vivo and in vitro experimental models. Furthermore, its influence on the mucosal layer adhering the gastric wall in indomethacin-treated rats was considered. Ranitidine was selected as a reference drug. The results obtained demonstrated that the new molecule, at variance with ranitidine, exerts antiulcer activity mainly enhancing the gastric mucosal integrity and simultaneously inhibiting the gastric acid hypersecretion evoked exclusively by cholinergic pulses. Therefore, an involvement of a neuronal rather than an effectorial mechanism has been suggested. Due to these mechanisms of action it clearly differentiates from ranitidine and its possible application in the peptic disease resistant to H2-blockers could be speculated.

AB - The present study investigates the antisecretory and antiulcer mechanisms of a new indenopyridazinone derivative previously reported to inhibit gastric acid secretion in pylorus-ligated rats and to prevent gastric ulcerations induced by indomethacin or ethanol in the same animal species. The new compound was tested on the acid hypersecretion induced by histamine, pentagastrin and bethanechol in in vivo and in vitro experimental models. Furthermore, its influence on the mucosal layer adhering the gastric wall in indomethacin-treated rats was considered. Ranitidine was selected as a reference drug. The results obtained demonstrated that the new molecule, at variance with ranitidine, exerts antiulcer activity mainly enhancing the gastric mucosal integrity and simultaneously inhibiting the gastric acid hypersecretion evoked exclusively by cholinergic pulses. Therefore, an involvement of a neuronal rather than an effectorial mechanism has been suggested. Due to these mechanisms of action it clearly differentiates from ranitidine and its possible application in the peptic disease resistant to H2-blockers could be speculated.

KW - Antiulcer-antisecretory activity

KW - Gastric mucosal barrier

KW - In vivo-in vitro functional assays

KW - Indenopirydazinone derivative

KW - Ranitidine

UR - http://www.scopus.com/inward/record.url?scp=0031148543&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031148543&partnerID=8YFLogxK

U2 - 10.1006/phrs.1997.0168

DO - 10.1006/phrs.1997.0168

M3 - Article

VL - 35

SP - 487

EP - 492

JO - Pharmacological Research

JF - Pharmacological Research

SN - 1043-6618

IS - 5

ER -